The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014

Katrina F. Trivers 1,* , Juan L. Rodriguez 1

1 Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA2 Oregon Health Authority, Portland, OR 97232, USA3 Georgia Department of Public Health, Atlanta, GA 30303-3142, USA4 Michigan Department of Health and Human Services, Lansing, MI 48909, USA† These authors contributed equally to this work.

* Author to whom correspondence should be addressed.

Received: 31 August 2015 / Revised: 25 September 2015 / Accepted: 8 October 2015 / Published: 15 October 2015

(This article belongs to the Special Issue Implementation of Public Health Genomics)

View Full-Text | Download PDF [245 KB, uploaded 15 October 2015] | Browse Figure

Abstract

In 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Disease Control and Prevention (CDC), released a three-year funding opportunity announcement (FOA) for a competitive, non-research cooperative agreement. The agreement enhanced the capacities of state health departments to promote the application of best practices for evidence-based breast cancer genomics through education, surveillance, and policy activities. The FOA required that applicants focus on activities related to hereditary breast and ovarian cancer (HBOC). The DCPC funded three states: Georgia, Michigan, and Oregon. Georgia was a first-time recipient of cancer genomics funding, whereas Michigan and Oregon had long standing activities in cancer genomics and had received CDC funding in the past. By the end of the funding period, each state had well-functioning and impactful state-based programs in breast cancer genomics. This article highlights the impact of a few key state activities by using CDC’s Science Impact Framework. There were challenges to implementing public health genomics programs, including the need to develop relevant partnerships, the highly technical nature of the subject matter, a lack of genetic services in certain areas, and the difficulty in funding genetic services. Georgia, Michigan, and Oregon have served as models for others interested in initiating or expanding cancer genomics programs, and they helped to determine what works well for promoting and integrating public health genomics into existing systems.

Keywords: genomics; genetic services; implementation; state health departments; BRCA; breast cancer; ovarian cancer;hereditary breast; ovarian cancer

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.